Patent ID: 8575130
Filing Date: 2013-11-05
Classification: A61K,A61P

Abstract:
1. A mixture of hyaluronic acid for treating inflammatory bowel disease (IBD) consisting essentially of hyaluronic acids with a lower molecule weight (Mw of LMWHA) and a higher molecule weight (Mw of HMWHA); an average Mw of LMWHA is 1 million Da, and an average Mw of HMWHA is 2 million Da; and a mixing ratio of said LMWHA and said HMWHA is in a range from 20:80 to 80:20, wherein the concentration of the mixture of said LMWHA and said HMWHA in a solution is 0.5 mg/mL to 50 mg/mL.